Eriptosis: mecanismos moleculares y su implicación en la enfermedad aterotrombótica
Authors:
- Fernando Manzur-JattinFMFernando Manzur-Jattin
- Neda Álvarez-OrtegaNÁNeda Álvarez-Ortega
- Carlos Moneriz-PretellCMCarlos Moneriz-Pretell
- Hugo Corrales-SantanderHCHugo Corrales-Santander
- Kevin Cantillo-GarcíaKCKevin Cantillo-García
Open Access
- 1 May 2016
- journal article
- Published by Instituto Mexicano del Seguro Social in Revista Colombiana de Cardiología
- Vol. 23 (3) , 218-226
Abstract
ResumenIntroducciónLa eriptosis se ha descrito como el proceso de muerte celular programada en el eritrocito antes de la senectud. Puede desencadenarse en situaciones como: el estrés osmótico, el estrés oxidativo, la exposición a metales pesados, entre otros factores. Diversos estudios sugieren que los eritrocitos pueden desempeñar un papel activo en la hemostasia normal o anormal en ciertas condiciones en las que se produce perturbación de la membrana de estas células.ObjetivoDescribir los mecanismos involucrados en la eriptosis y su estrecha relación con los procesos de adhesión a la pared vascular que conllevan a la enfermedad trombótica.MétodoSe hizo una revisión narrativa a partir de la literatura encontrada en las bases de datos PubMed y Science Direct utilizando las palabras claves. Se seleccionaron 51 artículos originales, 20 revisiones de la literatura y un estudio de casos, que se ajustaban a las exigencias del objetivo. Se revisaron los resúmenes de forma separada e independiente. Seguidamente se buscaron las publicaciones en el texto completo para la revisión.ConclusionesLa eriptosis se caracteriza por la disminución del volumen celular, la vesiculación y la translocación del fosfatidil serina hacia la superficie externa de la membrana plasmática. Las alteraciones en la distribución de los fosfolípidos favorecen los procesos de adhesión celular a la pared vascular, conllevando al deterioro de la microcirculación, lo cual puede ocasionar importantes trastornos a nivel cardiovascular. La comprensión y el esclarecimiento de la eriptosis pueden ser esenciales para la búsqueda de nuevas dianas terapéuticas, encaminadas a ofrecer otras alternativas farmacológicas en el tratamiento de la enfermedad cardiovascular.AbstractIntroductionEryptosis has been described as programmed process of cellular death in erythrocytes before old age. It can be triggered, among other factors, by situations such as osmotic stress, oxidative stress or exposure to heavy metals. Several studies suggest that erythrocytes can play an active role in normal or abnormal haemostasis in certain conditions where the membrane of these cells is perturbed.ObjetiveTo describe the mechanisms involved in eryptosis and their close relationship with the processes of adhesion to the vascular wall that entail the thrombotic disease.MethodsA narrative review was carried out from the literature found in data base PubMed and Science Direct by using the key words. 51 original articles, 20 literature reviews and one case study complying with the requirements were selected. Abstracts were reviewed separately and independently. Complete publications were then located for review.ConclusionsEryptosis is characterised by the decrease in cell volume, the vesiculation and the translocation of phosphatidylserine towards the outer surface of the plasma membrane. Disorders in the distribution of the phospholipids favour processes of cell adhesion to the vascular wall, causing impairment of microcirculation, which can result in important cardiovascular diseases. Understanding and clarifying eryptosis could be essential for finding new therapeutic targets, aimed at offering other pharmacological alternatives for the treatment of cardiovascular diseasesKeywords
This publication has 67 references indexed in Scilit:
- Adhesion of Annexin 7 Deficient Erythrocytes to Endothelial CellsPLOS ONE, 2013
- Functional consequences of sphingomyelinase-induced changes in erythrocyte membrane structureCell Death & Disease, 2012
- Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen speciesBritish Journal of Pharmacology, 2011
- Atypical Hemolytic Uremic Syndrome Associated with Mutations in Complement Regulator GenesSeminars in Thrombosis and Hemostasis, 2010
- Procoagulant and prothrombotic activation of human erythrocytes by phosphatidic acidAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Low-Level Mercury Can Enhance Procoagulant Activity of Erythrocytes: A New Contributing Factor for Mercury-Related Thrombotic DiseaseEnvironmental Health Perspectives, 2010
- Lysophosphatidic Acid Induces Thrombogenic Activity Through Phosphatidylserine Exposure and Procoagulant Microvesicle Generation in Human ErythrocytesArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosisBlood, 2003
- Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondriaCell Death & Differentiation, 2001
- Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosisCell Death & Differentiation, 2001